2-hydroxymethyl-3,4,5-trihydroxy-1-ben zilpiperidine derivatives as inhibitors of glucosylceramide

Details for Australian Patent Application No. 2004247469 (hide)

Owner Actelion Pharmaceuticals Ltd

Inventors Orchard, Michael Glen

Agent A J Park

Pub. Number AU-B-2004247469

PCT Pub. Number WO2004/111002

Priority 0313678.5 13.06.03 GB

Filing date 9 June 2004

Wipo publication date 23 December 2004

Acceptance publication date 19 November 2009

International Classifications

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 35/00 (2006.01) Antineoplastic agents

C07D 211/46 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2004/111002 Priority application(s): WO2004/111002

19 November 2009 Application Accepted

  Published as AU-B-2004247469

18 March 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004247470-Thienopyrimidine derivatives as potassium channel inhibitors

2004247468-2-hydroxymethyl-3,4,5-trihydroxy-1-(4-p entlyoxybenzyl) piperidine as glucosylceramide synthase (GCS)